Front-of-package Warning Labels for Sugar Content in Sugar-sweetened Beverages

NCT07570576 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2800

Last updated 2026-05-12

No results posted yet for this study

Summary

The goal of this online randomized trial is to examine the effectiveness of Front-of-package (FOP) warning labels for added sugar content on the intent-to-purchases of SSBs in an affluent Asian setting. We hypothesize the FOP warning labels are significantly associated with a reduction of consumers' purchase intention of sugar-sweetened beverages (SSBs).

Conditions

  • Obesity & Overweight

Interventions

OTHER

UK-style traffic light labels

UK-style traffic light labels displaying "HIGH ADDED SUGAR" in a red circle, "MEDIUM ADDED SUGAR" in a yellow circle, "LOW ADDED SUGAR" in a green circle, or "ZERO ADDED SUGAR" in a green circle

OTHER

Chile-style octagonal labels

Chile-style octagonal labels displaying "HIGH ADDED SUGAR"

OTHER

text warning labels

text warning labels stating that drinking beverages with added sugar contributes to diabetes and tooth decay, applied to low-, medium-, and high-added-sugar beverages

OTHER

text-and-graphic warning labels

text-and-graphic warning labels displaying the same message as the text warning label with simple graphics representing diabetes and tooth decay, applied to low-, medium-, and high-added-sugar beverages

OTHER

teaspoon labels

teaspoon labels showing the number of teaspoons of added sugar per 100 mL, applied to all added-sugar levels

OTHER

Hong Kong-style labels

Hong Kong-style labels, adapted from the voluntary "Salt / Sugar" Label Scheme for prepackaged food products, displaying "LOW SUGAR" or "NO SUGAR" inside a diamond shape with a tick mark at the bottom

Sponsors & Collaborators

  • Chinese University of Hong Kong

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-05-01
Primary Completion
2027-04-30
Completion
2028-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07570576 on ClinicalTrials.gov